香港市場銘柄情報

02252 MEDBOT-B

銘柄追加
  • 13.300
  • +0.400+3.10%
寄付前 04/26 16:08 CST
127.49億時価総額-11416直近PER
日中
  • 5日
  • 日足
  • 週足
  • 月足
  • Q足
  • 年足

注文・約定分析

単位: --

積極売買トレンド

日中

データなし

ニュース

コメント

    $MEDBOT-B(02252.HK)$
    Finally on, but did not hit a new subscription. The market is not friendly to unprofitable start-ups, and expect a more comfortable price. Kingsley bio and minimally invasive robotics are the most focused directions for innovative drugs and innovative medical devices in the future. It is nothing more than the time and rhythm of the completion of the warehouse.
    $MEDBOT-B(02252.HK)$
    The big Four are 10 years ahead of their time in technology, waiting for the world to catch up, and they have their own medical robots. Da Vinci launched its products in 2000 based on the underlying technology of the robot industry. The more cases there are, the more powerful they are.
    $MEDBOT-B(02252.HK)$ Personal View of minimally invasive robot
    Several key points, not profitable, High ling IPO increase, JPMORGAN Chase sponsor, expected 50% callback, IPO for the previous investment rise range is still ok, speculation new mood has not recovered;
    In summary, in terms of playing new, the probability of winning is almost 50/50, the odds are not high, if the call back to break the resistance to save slightly bigger
    $MEDBOT-B(02252.HK)$ Make money on short-term market sentiment. Since we are only new, we need to have a clear positioning, just to make money in the dark market or the first two days of the listing. So, listed the first time is up or down for us is the most important! Even if you think that the future of this new stock must be bright, the future must be a big bull, and we hit the new is not related to, because we can not wait for the distant future.
もっと見る

分析

アナリスト評価

データなし

目標株価

データなし

ホット
香港株
総合人気
コード
現在値
変化率